NFE2L2 and early-onset autosomal dominant Alzheimer disease: The demonstration that Nrf2 inducer SFN provides an improvement in cognitive function and amyloid pathology in PS1V97L‐Tg mice, has supported the importance of the Nrf2/ARE pathway in Alzheimer’s disease.